187 related articles for article (PubMed ID: 32487562)
1. Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.
Nichols GA; Ustyugova A; Déruaz-Luyet A; O'Keeffe-Rosetti M; Brodovicz KG
J Am Soc Nephrol; 2020 Jul; 31(7):1594-1601. PubMed ID: 32487562
[TBL] [Abstract][Full Text] [Related]
2. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
[No Abstract] [Full Text] [Related]
3. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
Nichols GA; Déruaz-Luyet A; Brodovicz KG; Kimes TM; Rosales AG; Hauske SJ
BMC Nephrol; 2020 May; 21(1):167. PubMed ID: 32380961
[TBL] [Abstract][Full Text] [Related]
4. Health system costs for individual and comorbid noncommunicable diseases: An analysis of publicly funded health events from New Zealand.
Blakely T; Kvizhinadze G; Atkinson J; Dieleman J; Clarke P
PLoS Med; 2019 Jan; 16(1):e1002716. PubMed ID: 30620729
[TBL] [Abstract][Full Text] [Related]
5. Healthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.
Eriksson JK; Neovius M; Jacobson SH; Elinder CG; Hylander B
BMJ Open; 2016 Oct; 6(10):e012062. PubMed ID: 27855091
[TBL] [Abstract][Full Text] [Related]
6. Cost of chronic kidney disease attributable to diabetes from the perspective of the Brazilian Unified Health System.
Goncalves GMR; Silva END
PLoS One; 2018; 13(10):e0203992. PubMed ID: 30273345
[TBL] [Abstract][Full Text] [Related]
7. Potentially Preventable Hospitalization among Patients with CKD and High Inpatient Use.
Ronksley PE; Hemmelgarn BR; Manns BJ; Wick J; James MT; Ravani P; Quinn RR; Scott-Douglas N; Lewanczuk R; Tonelli M
Clin J Am Soc Nephrol; 2016 Nov; 11(11):2022-2031. PubMed ID: 27821636
[TBL] [Abstract][Full Text] [Related]
8. What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
Kent S; Schlackow I; Lozano-Kühne J; Reith C; Emberson J; Haynes R; Gray A; Cass A; Baigent C; Landray MJ; Herrington W; Mihaylova B;
BMC Nephrol; 2015 Apr; 16():65. PubMed ID: 25924679
[TBL] [Abstract][Full Text] [Related]
9. Predictors and Outcomes of Health-Related Quality of Life in Adults with CKD.
Porter AC; Lash JP; Xie D; Pan Q; DeLuca J; Kanthety R; Kusek JW; Lora CM; Nessel L; Ricardo AC; Wright Nunes J; Fischer MJ;
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1154-1162. PubMed ID: 27246012
[TBL] [Abstract][Full Text] [Related]
10. Economic burden of comorbid chronic kidney disease and diabetes.
McQueen RB; Farahbakhshian S; Bell KF; Nair KV; Saseen JJ
J Med Econ; 2017 Jun; 20(6):585-591. PubMed ID: 28128669
[TBL] [Abstract][Full Text] [Related]
11. The economic burden of progressive chronic kidney disease among patients with type 2 diabetes.
Vupputuri S; Kimes TM; Calloway MO; Christian JB; Bruhn D; Martin AA; Nichols GA
J Diabetes Complications; 2014; 28(1):10-6. PubMed ID: 24211091
[TBL] [Abstract][Full Text] [Related]
12. Contemporary rates and predictors of fast progression of chronic kidney disease in adults with and without diabetes mellitus.
Go AS; Yang J; Tan TC; Cabrera CS; Stefansson BV; Greasley PJ; Ordonez JD;
BMC Nephrol; 2018 Jun; 19(1):146. PubMed ID: 29929484
[TBL] [Abstract][Full Text] [Related]
13. The Impact of Cardiovascular Disease and Chronic Kidney Disease on Life Expectancy and Direct Medical Cost in a 10-Year Diabetes Cohort Study.
Wan EYF; Chin WY; Yu EYT; Wong ICK; Chan EWY; Li SX; Cheung NKL; Wang Y; Lam CLK
Diabetes Care; 2020 Aug; 43(8):1750-1758. PubMed ID: 32457057
[TBL] [Abstract][Full Text] [Related]
14. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
[No Abstract] [Full Text] [Related]
15. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
[TBL] [Abstract][Full Text] [Related]
16. Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis.
McEwan P; Hafner M; Jha V; Correa-Rotter R; Chernin G; De Nicola L; Villanueva R; Wheeler DC; Barone S; Nolan S; Garcia Sanchez JJ
J Med Econ; 2023; 26(1):1407-1416. PubMed ID: 37807895
[TBL] [Abstract][Full Text] [Related]
17. Burden and Cost of Caring for US Veterans With CKD: Initial Findings From the VA Renal Information System (VA-REINS).
Saran R; Pearson A; Tilea A; Shahinian V; Bragg-Gresham J; Heung M; Hutton DW; Steffick D; Zheng K; Morgenstern H; Gillespie BW; Leichtman A; Young E; O'Hare AM; Fischer M; Hotchkiss J; Siew E; Hynes D; Fried L; Balkovetz D; Sovern K; Liu CF; Crowley S; ;
Am J Kidney Dis; 2021 Mar; 77(3):397-405. PubMed ID: 32890592
[TBL] [Abstract][Full Text] [Related]
18. All-cause costs increase exponentially with increased chronic kidney disease stage.
Golestaneh L; Alvarez PJ; Reaven NL; Funk SE; McGaughey KJ; Romero A; Brenner MS; Onuigbo M
Am J Manag Care; 2017 Jun; 23(10 Suppl):S163-S172. PubMed ID: 28978205
[TBL] [Abstract][Full Text] [Related]
19. The association between the severity of chronic kidney disease and medical costs among patients with type 2 diabetes.
Lage MJ; Boye KS; Bae JP; Wu J; Mody R; Botros FT
J Med Econ; 2019 May; 22(5):447-454. PubMed ID: 30736708
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Economic Impact of Hyperkalemia in Patients with Chronic Kidney Disease and Heart Failure.
Polson M; Lord TC; Kangethe A; Speicher L; Farnum C; Brenner M; Oestreicher N; Alvarez P
J Manag Care Spec Pharm; 2017 Apr; 23(4-a Suppl):S2-S9. PubMed ID: 28436256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
